Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedAug 28, 2019Clear Eyes Redness Relief Hand Pocket Pal Tray DisplayCGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product...Medtech Products, Inc. · D-1835-2019Class IITerminatedAug 28, 2019Clear eyes REDNESS RELIEFCGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product...Medtech Products, Inc. · D-1834-2019Class IITerminatedAug 28, 2019Clear Eyes Redness Relief Handy Pocket Pal Club Pak DisplayCGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product...Medtech Products, Inc. · D-1833-2019Class IITerminatedAug 28, 2019Clear Eyes Maximum Itchy Eye Relief Sidekick Floor Stand DisplayCGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product...Medtech Products, Inc. · D-1832-2019Class IITerminatedAug 28, 2019Clear Eyes Maximum Redness Relief Club Pack DisplayCGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product...Medtech Products, Inc. · D-1831-2019Class IITerminatedAug 28, 2019Clear Eyes Maximum Itchy Eye Relief Sidekick Floor Stand DisplayCGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product...Medtech Products, Inc. · D-1830-2019Class IITerminatedAug 28, 2019Clear Eyes Redness Relief Club Pack DisplayCGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product...Medtech Products, Inc. · D-1829-2019Class IITerminatedAug 28, 2019Clear Eyes Assorted Sidekick Floor Stand DisplayCGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product...Medtech Products, Inc. · D-1828-2019Class IITerminatedAug 28, 2019Clear Eyes Maximum Redness and Itchy Eye Relief Sidekick DisplayCGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product...Medtech Products, Inc. · D-1827-2019Class IITerminatedAug 28, 2019Clear Eyes Assorted IRC DisplayCGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product...Medtech Products, Inc. · D-1826-2019Class IITerminatedAug 28, 2019Clear eyes MAXIMUM REDNESS RELIEFCGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product...Medtech Products, Inc. · D-1825-2019Class IITerminatedAug 28, 2019Clear eyes MAXIMUM ITCHY EYE RELIEFCGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product...Medtech Products, Inc. · D-1824-2019Class IITerminatedAug 28, 2019Clear eyes REDNESS RELIEFCGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product...Medtech Products, Inc. · D-1823-2019Class IITerminatedAug 28, 2019Clear eyes REDNESS RELIEFCGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product...Medtech Products, Inc. · D-1822-2019Class IITerminatedAug 21, 2019Tamsulosin Hydrochloride CapsulesFailed Dissolution SpecificationsMacleods Pharma Usa Inc · D-1844-2019Class IITerminatedAug 21, 2019CarbamazepineFailed Dissolution SpecificationsAmerican Health Packaging · D-1821-2019Class IITerminatedAug 21, 2019Aspirin and Extended-release Dipyridamole CapsulesFailed Impurities/Degradation Specifications; out of specification result for an unknown impurity in stability samples.American Health Packaging · D-1820-2019Class IITerminatedAug 21, 2019FERRIC CARBOXYMALTOSE 750mg/50ml NS IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1819-2019Class IITerminatedAug 21, 2019VINCRISTINE 1 MG /50 ML NS IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1818-2019Class IITerminatedAug 21, 2019VINBLASTINE 10.9 MG / 100 ML D5W IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1817-2019Class IITerminatedAug 21, 2019VELCADE 2.1 mg / 0.84 ml SQ SYRINGELack of Assurance of SterilityInfusion Options, Inc. · D-1816-2019Class IITerminatedAug 21, 2019TRASTUZUMAB 427 MG / 250 ml NS IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1815-2019Class IITerminatedAug 21, 2019TOPOTECAN 1.24 MG / 100 ML NS IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1814-2019Class IITerminatedAug 21, 2019SOLIRIS 1200 MG QS 240 ML NACL0.9% IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1813-2019Class IITerminatedAug 21, 2019Sodium Chloride 0.9% 1 LITER WITH Potassium Chloride 20 mEqLack of Assurance of SterilityInfusion Options, Inc. · D-1812-2019Class IITerminatedAug 21, 2019RomiPLOStim 700 MCG/ 1.4 ML SQ SYRLack of Assurance of SterilityInfusion Options, Inc. · D-1811-2019Class IITerminatedAug 21, 2019RITUXIMAB 575 MG / 250 ml 0.9% NACL IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1810-2019Class IITerminatedAug 21, 2019RITUXAN 728 MG QS 728 mL 0.9% NACL IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1809-2019Class IITerminatedAug 21, 2019REMICADE 680 MG QS 250 ML 0.9% NACL IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1808-2019Class IITerminatedAug 21, 2019RAMUCIRUMAB 457 MG QS 250 ML NS IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1807-2019Class IITerminatedAug 21, 2019PRESERVATIVE FREE 0.9% NACL 5 ML SYRLack of Assurance of SterilityInfusion Options, Inc. · D-1806-2019Class IITerminatedAug 21, 2019PERTUZUMAB 840 MG/250 ml0.9% NACL IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1805-2019Class IITerminatedAug 21, 2019PERJETA 420 MG/250 ml 0.9% NACL IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1804-2019Class IITerminatedAug 21, 2019PEMETREXED 910 MG QS 100 ML NS IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1803-2019Class IITerminatedAug 21, 2019PANITUMUMAB 400 MG / 100 ml NS IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1802-2019Class IITerminatedAug 21, 2019PEMBROLIZUMAB 200 MG / 100 ML NS IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1801-2019Class IITerminatedAug 21, 2019PACLITAXEL PROTEIN 175 MG/100 ML NS IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1800-2019Class IITerminatedAug 21, 2019PACLITAXEL ALBUMIN 185 mg /100 ml NS IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1799-2019Class IITerminatedAug 21, 2019PACLITAXEL 258 MG / 500 ML NS IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1798-2019Class IITerminatedAug 21, 2019OXALIPLATIN 145 MG /250 ML D5W IVPBLack of Assurance of SterilityInfusion Options, Inc. · D-1797-2019

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.